Zhou H - Search Results

1

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.

Zhang X, Zhang J, Zhou H, Fan G, Li Q. Zhang X, et al. Among authors: zhou h. J Cancer. 2019 Oct 18;10(25):6327-6340. doi: 10.7150/jca.34171. eCollection 2019. J Cancer. 2019. PMID: 31772665 Free PMC article. Review.

2

Overlapping and unique roles played by ROCK1 and 2 in the modulation of coding and long noncoding RNA expression.

Zhou HM, Zhang JG, Zhang X, Fan GR, Liu GL, Li Q. Zhou HM, et al. BMC Genomics. 2019 May 22;20(1):409. doi: 10.1186/s12864-019-5715-0. BMC Genomics. 2019. PMID: 31117934 Free PMC article.

3

Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.

Zhang JG, Zhou HM, Zhang X, Mu W, Hu JN, Liu GL, Li Q. Zhang JG, et al. BMC Cancer. 2020 Jan 13;20(1):32. doi: 10.1186/s12885-019-6501-8. BMC Cancer. 2020. PMID: 31931758 Free PMC article.

4

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy.

Wu Y, Zhang J, Zhang X, Zhou H, Liu G, Li Q. Wu Y, et al. Among authors: zhou h. Front Pharmacol. 2020 Mar 6;11:198. doi: 10.3389/fphar.2020.00198. eCollection 2020. Front Pharmacol. 2020. PMID: 32210805 Free PMC article. Review.

5

Rho kinase mediates transforming growth factor-β1-induced vasculogenic mimicry formation: involvement of the epithelial-mesenchymal transition and cancer stemness activity.

Zhang X, Zhang J, Zhou H, Liu G, Li Q. Zhang X, et al. Among authors: zhou h. Acta Biochim Biophys Sin (Shanghai). 2020 Apr 20;52(4):411-420. doi: 10.1093/abbs/gmaa014. Acta Biochim Biophys Sin (Shanghai). 2020. PMID: 32296834 Free article.

6

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.

Zhou HM, Zhang JG, Zhang X, Li Q. Zhou HM, et al. Signal Transduct Target Ther. 2021 Feb 15;6(1):62. doi: 10.1038/s41392-020-00430-1. Signal Transduct Target Ther. 2021. PMID: 33589595 Free PMC article. Review.

7

The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.

Zhang X, Zhang JG, Mu W, Zhou HM, Liu GL, Li Q. Zhang X, et al. Phytomedicine. 2021 Nov;92:153740. doi: 10.1016/j.phymed.2021.153740. Epub 2021 Sep 8. Phytomedicine. 2021. PMID: 34600176

8

A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.

Yang H, Chen D, Wu Y, Zhou H, Diao W, Liu G, Li Q. Yang H, et al. Among authors: zhou h. Cancer Metab. 2023 Dec 18;11(1):27. doi: 10.1186/s40170-023-00311-5. Cancer Metab. 2023. PMID: 38111012 Free PMC article.

9

Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.

Zhou HM, Chen DH, Diao WJ, Wu YF, Zhang JG, Zhong L, Jiang ZY, Zhang X, Liu GL, Li Q. Zhou HM, et al. Exp Cell Res. 2024 Mar 1;436(1):113956. doi: 10.1016/j.yexcr.2024.113956. Epub 2024 Feb 8. Exp Cell Res. 2024. PMID: 38341081 Free article.

10

Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target.

Shi L, Mao N, Zheng Z, Liu J, Zhou H, Hou J, Su Y. Shi L, et al. Among authors: zhou h. Int J Med Sci. 2025 Jan 6;22(3):604-615. doi: 10.7150/ijms.103834. eCollection 2025. Int J Med Sci. 2025. PMID: 39898245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,009 results

Search Page

Filters